Researchers at the University of Colorado Anschutz Cancer Center have uncovered a metabolic vulnerability in the stem cells responsible for driving high-risk myelodysplastic syndromes (MDS), raising the possibility of treatments designed to attack malignant blood-forming cells while sparing their healthy counterparts.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045